Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Weight Loss Drugs Market Growth 2022-2028

  • LP 4837317
  • 102 Pages
  • February 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Weight Loss Drugs will have significant change from previous year. According to our (LP Information) latest study, the global Weight Loss Drugs market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Weight Loss Drugs market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Weight Loss Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Weight Loss Drugs market, reaching US$ million by the year 2028. As for the Europe Weight Loss Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Weight Loss Drugs players cover Roche, GSK group, Teva, and Sandoz(Novartis), etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Weight Loss Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Liauid Weight Loss Drugs

Tablets Weight Loss Drugs

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Weight-reducing Aid

Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Roche

GSK group

Teva

Sandoz(Novartis)

STADA-VN J.V.Co., Ltd

Hexal AG

National Company For Pharmaceutical Industry

Lunan Pharmaceutical Group Corporation

Zein Pharmaceutical

Hisun

Taj Pharmaceuticals Ltd

Kabir Life Sciences & Research

Dm Pharma

China Zhongshan Pharm

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Weight Loss Drugs Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Weight Loss Drugs by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Weight Loss Drugs by Country/Region, 2017, 2022 & 2028

2.2 Weight Loss Drugs Segment by Type

2.2.1 Liauid Weight Loss Drugs

2.2.2 Tablets Weight Loss Drugs

2.3 Weight Loss Drugs Sales by Type

2.3.1 Global Weight Loss Drugs Sales Market Share by Type (2017-2022)

2.3.2 Global Weight Loss Drugs Revenue and Market Share by Type (2017-2022)

2.3.3 Global Weight Loss Drugs Sale Price by Type (2017-2022)

2.4 Weight Loss Drugs Segment by Application

2.4.1 Weight-reducing Aid

2.4.2 Other

2.5 Weight Loss Drugs Sales by Application

2.5.1 Global Weight Loss Drugs Sale Market Share by Application (2017-2022)

2.5.2 Global Weight Loss Drugs Revenue and Market Share by Application (2017-2022)

2.5.3 Global Weight Loss Drugs Sale Price by Application (2017-2022)

3 Global Weight Loss Drugs by Company

3.1 Global Weight Loss Drugs Breakdown Data by Company

3.1.1 Global Weight Loss Drugs Annual Sales by Company (2020-2022)

3.1.2 Global Weight Loss Drugs Sales Market Share by Company (2020-2022)

3.2 Global Weight Loss Drugs Annual Revenue by Company (2020-2022)

3.2.1 Global Weight Loss Drugs Revenue by Company (2020-2022)

3.2.2 Global Weight Loss Drugs Revenue Market Share by Company (2020-2022)

3.3 Global Weight Loss Drugs Sale Price by Company

3.4 Key Manufacturers Weight Loss Drugs Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Weight Loss Drugs Product Location Distribution

3.4.2 Players Weight Loss Drugs Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Weight Loss Drugs by Geographic Region

4.1 World Historic Weight Loss Drugs Market Size by Geographic Region (2017-2022)

4.1.1 Global Weight Loss Drugs Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Weight Loss Drugs Annual Revenue by Geographic Region

4.2 World Historic Weight Loss Drugs Market Size by Country/Region (2017-2022)

4.2.1 Global Weight Loss Drugs Annual Sales by Country/Region (2017-2022)

4.2.2 Global Weight Loss Drugs Annual Revenue by Country/Region

4.3 Americas Weight Loss Drugs Sales Growth

4.4 APAC Weight Loss Drugs Sales Growth

4.5 Europe Weight Loss Drugs Sales Growth

4.6 Middle East & Africa Weight Loss Drugs Sales Growth

5 Americas

5.1 Americas Weight Loss Drugs Sales by Country

5.1.1 Americas Weight Loss Drugs Sales by Country (2017-2022)

5.1.2 Americas Weight Loss Drugs Revenue by Country (2017-2022)

5.2 Americas Weight Loss Drugs Sales by Type

5.3 Americas Weight Loss Drugs Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Weight Loss Drugs Sales by Region

6.1.1 APAC Weight Loss Drugs Sales by Region (2017-2022)

6.1.2 APAC Weight Loss Drugs Revenue by Region (2017-2022)

6.2 APAC Weight Loss Drugs Sales by Type

6.3 APAC Weight Loss Drugs Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Weight Loss Drugs by Country

7.1.1 Europe Weight Loss Drugs Sales by Country (2017-2022)

7.1.2 Europe Weight Loss Drugs Revenue by Country (2017-2022)

7.2 Europe Weight Loss Drugs Sales by Type

7.3 Europe Weight Loss Drugs Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Weight Loss Drugs by Country

8.1.1 Middle East & Africa Weight Loss Drugs Sales by Country (2017-2022)

8.1.2 Middle East & Africa Weight Loss Drugs Revenue by Country (2017-2022)

8.2 Middle East & Africa Weight Loss Drugs Sales by Type

8.3 Middle East & Africa Weight Loss Drugs Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Weight Loss Drugs

10.3 Manufacturing Process Analysis of Weight Loss Drugs

10.4 Industry Chain Structure of Weight Loss Drugs

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Weight Loss Drugs Distributors

11.3 Weight Loss Drugs Customer

12 World Forecast Review for Weight Loss Drugs by Geographic Region

12.1 Global Weight Loss Drugs Market Size Forecast by Region

12.1.1 Global Weight Loss Drugs Forecast by Region (2023-2028)

12.1.2 Global Weight Loss Drugs Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Weight Loss Drugs Forecast by Type

12.7 Global Weight Loss Drugs Forecast by Application

13 Key Players Analysis

13.1 Roche

13.1.1 Roche Company Information

13.1.2 Roche Weight Loss Drugs Product Offered

13.1.3 Roche Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Roche Main Business Overview

13.1.5 Roche Latest Developments

13.2 GSK group

13.2.1 GSK group Company Information

13.2.2 GSK group Weight Loss Drugs Product Offered

13.2.3 GSK group Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 GSK group Main Business Overview

13.2.5 GSK group Latest Developments

13.3 Teva

13.3.1 Teva Company Information

13.3.2 Teva Weight Loss Drugs Product Offered

13.3.3 Teva Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Teva Main Business Overview

13.3.5 Teva Latest Developments

13.4 Sandoz(Novartis)

13.4.1 Sandoz(Novartis) Company Information

13.4.2 Sandoz(Novartis) Weight Loss Drugs Product Offered

13.4.3 Sandoz(Novartis) Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Sandoz(Novartis) Main Business Overview

13.4.5 Sandoz(Novartis) Latest Developments

13.5 STADA-VN J.V.Co., Ltd

13.5.1 STADA-VN J.V.Co., Ltd Company Information

13.5.2 STADA-VN J.V.Co., Ltd Weight Loss Drugs Product Offered

13.5.3 STADA-VN J.V.Co., Ltd Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 STADA-VN J.V.Co., Ltd Main Business Overview

13.5.5 STADA-VN J.V.Co., Ltd Latest Developments

13.6 Hexal AG

13.6.1 Hexal AG Company Information

13.6.2 Hexal AG Weight Loss Drugs Product Offered

13.6.3 Hexal AG Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Hexal AG Main Business Overview

13.6.5 Hexal AG Latest Developments

13.7 National Company For Pharmaceutical Industry

13.7.1 National Company For Pharmaceutical Industry Company Information

13.7.2 National Company For Pharmaceutical Industry Weight Loss Drugs Product Offered

13.7.3 National Company For Pharmaceutical Industry Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 National Company For Pharmaceutical Industry Main Business Overview

13.7.5 National Company For Pharmaceutical Industry Latest Developments

13.8 Lunan Pharmaceutical Group Corporation

13.8.1 Lunan Pharmaceutical Group Corporation Company Information

13.8.2 Lunan Pharmaceutical Group Corporation Weight Loss Drugs Product Offered

13.8.3 Lunan Pharmaceutical Group Corporation Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Lunan Pharmaceutical Group Corporation Main Business Overview

13.8.5 Lunan Pharmaceutical Group Corporation Latest Developments

13.9 Zein Pharmaceutical

13.9.1 Zein Pharmaceutical Company Information

13.9.2 Zein Pharmaceutical Weight Loss Drugs Product Offered

13.9.3 Zein Pharmaceutical Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Zein Pharmaceutical Main Business Overview

13.9.5 Zein Pharmaceutical Latest Developments

13.10 Hisun

13.10.1 Hisun Company Information

13.10.2 Hisun Weight Loss Drugs Product Offered

13.10.3 Hisun Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Hisun Main Business Overview

13.10.5 Hisun Latest Developments

13.11 Taj Pharmaceuticals Ltd

13.11.1 Taj Pharmaceuticals Ltd Company Information

13.11.2 Taj Pharmaceuticals Ltd Weight Loss Drugs Product Offered

13.11.3 Taj Pharmaceuticals Ltd Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Taj Pharmaceuticals Ltd Main Business Overview

13.11.5 Taj Pharmaceuticals Ltd Latest Developments

13.12 Kabir Life Sciences & Research

13.12.1 Kabir Life Sciences & Research Company Information

13.12.2 Kabir Life Sciences & Research Weight Loss Drugs Product Offered

13.12.3 Kabir Life Sciences & Research Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Kabir Life Sciences & Research Main Business Overview

13.12.5 Kabir Life Sciences & Research Latest Developments

13.13 Dm Pharma

13.13.1 Dm Pharma Company Information

13.13.2 Dm Pharma Weight Loss Drugs Product Offered

13.13.3 Dm Pharma Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Dm Pharma Main Business Overview

13.13.5 Dm Pharma Latest Developments

13.14 China Zhongshan Pharm

13.14.1 China Zhongshan Pharm Company Information

13.14.2 China Zhongshan Pharm Weight Loss Drugs Product Offered

13.14.3 China Zhongshan Pharm Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 China Zhongshan Pharm Main Business Overview

13.14.5 China Zhongshan Pharm Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Weight Loss Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Weight Loss Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Liauid Weight Loss Drugs

Table 4. Major Players of Tablets Weight Loss Drugs

Table 5. Global Weight Loss Drugs Sales by Type (2017-2022) & (K Tablets)

Table 6. Global Weight Loss Drugs Sales Market Share by Type (2017-2022)

Table 7. Global Weight Loss Drugs Revenue by Type (2017-2022) & ($ million)

Table 8. Global Weight Loss Drugs Revenue Market Share by Type (2017-2022)

Table 9. Global Weight Loss Drugs Sale Price by Type (2017-2022) & (USD/Tablet)

Table 10. Global Weight Loss Drugs Sales by Application (2017-2022) & (K Tablets)

Table 11. Global Weight Loss Drugs Sales Market Share by Application (2017-2022)

Table 12. Global Weight Loss Drugs Revenue by Application (2017-2022)

Table 13. Global Weight Loss Drugs Revenue Market Share by Application (2017-2022)

Table 14. Global Weight Loss Drugs Sale Price by Application (2017-2022) & (USD/Tablet)

Table 15. Global Weight Loss Drugs Sales by Company (2020-2022) & (K Tablets)

Table 16. Global Weight Loss Drugs Sales Market Share by Company (2020-2022)

Table 17. Global Weight Loss Drugs Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Weight Loss Drugs Revenue Market Share by Company (2020-2022)

Table 19. Global Weight Loss Drugs Sale Price by Company (2020-2022) & (USD/Tablet)

Table 20. Key Manufacturers Weight Loss Drugs Producing Area Distribution and Sales Area

Table 21. Players Weight Loss Drugs Products Offered

Table 22. Weight Loss Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Weight Loss Drugs Sales by Geographic Region (2017-2022) & (K Tablets)

Table 26. Global Weight Loss Drugs Sales Market Share Geographic Region (2017-2022)

Table 27. Global Weight Loss Drugs Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Weight Loss Drugs Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Weight Loss Drugs Sales by Country/Region (2017-2022) & (K Tablets)

Table 30. Global Weight Loss Drugs Sales Market Share by Country/Region (2017-2022)

Table 31. Global Weight Loss Drugs Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Weight Loss Drugs Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Weight Loss Drugs Sales by Country (2017-2022) & (K Tablets)

Table 34. Americas Weight Loss Drugs Sales Market Share by Country (2017-2022)

Table 35. Americas Weight Loss Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Weight Loss Drugs Revenue Market Share by Country (2017-2022)

Table 37. Americas Weight Loss Drugs Sales by Type (2017-2022) & (K Tablets)

Table 38. Americas Weight Loss Drugs Sales Market Share by Type (2017-2022)

Table 39. Americas Weight Loss Drugs Sales by Application (2017-2022) & (K Tablets)

Table 40. Americas Weight Loss Drugs Sales Market Share by Application (2017-2022)

Table 41. APAC Weight Loss Drugs Sales by Region (2017-2022) & (K Tablets)

Table 42. APAC Weight Loss Drugs Sales Market Share by Region (2017-2022)

Table 43. APAC Weight Loss Drugs Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Weight Loss Drugs Revenue Market Share by Region (2017-2022)

Table 45. APAC Weight Loss Drugs Sales by Type (2017-2022) & (K Tablets)

Table 46. APAC Weight Loss Drugs Sales Market Share by Type (2017-2022)

Table 47. APAC Weight Loss Drugs Sales by Application (2017-2022) & (K Tablets)

Table 48. APAC Weight Loss Drugs Sales Market Share by Application (2017-2022)

Table 49. Europe Weight Loss Drugs Sales by Country (2017-2022) & (K Tablets)

Table 50. Europe Weight Loss Drugs Sales Market Share by Country (2017-2022)

Table 51. Europe Weight Loss Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Weight Loss Drugs Revenue Market Share by Country (2017-2022)

Table 53. Europe Weight Loss Drugs Sales by Type (2017-2022) & (K Tablets)

Table 54. Europe Weight Loss Drugs Sales Market Share by Type (2017-2022)

Table 55. Europe Weight Loss Drugs Sales by Application (2017-2022) & (K Tablets)

Table 56. Europe Weight Loss Drugs Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Weight Loss Drugs Sales by Country (2017-2022) & (K Tablets)

Table 58. Middle East & Africa Weight Loss Drugs Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Weight Loss Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Weight Loss Drugs Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Weight Loss Drugs Sales by Type (2017-2022) & (K Tablets)

Table 62. Middle East & Africa Weight Loss Drugs Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Weight Loss Drugs Sales by Application (2017-2022) & (K Tablets)

Table 64. Middle East & Africa Weight Loss Drugs Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Weight Loss Drugs

Table 66. Key Market Challenges & Risks of Weight Loss Drugs

Table 67. Key Industry Trends of Weight Loss Drugs

Table 68. Weight Loss Drugs Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Weight Loss Drugs Distributors List

Table 71. Weight Loss Drugs Customer List

Table 72. Global Weight Loss Drugs Sales Forecast by Region (2023-2028) & (K Tablets)

Table 73. Global Weight Loss Drugs Sales Market Forecast by Region

Table 74. Global Weight Loss Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Weight Loss Drugs Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Weight Loss Drugs Sales Forecast by Country (2023-2028) & (K Tablets)

Table 77. Americas Weight Loss Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Weight Loss Drugs Sales Forecast by Region (2023-2028) & (K Tablets)

Table 79. APAC Weight Loss Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Weight Loss Drugs Sales Forecast by Country (2023-2028) & (K Tablets)

Table 81. Europe Weight Loss Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Weight Loss Drugs Sales Forecast by Country (2023-2028) & (K Tablets)

Table 83. Middle East & Africa Weight Loss Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Weight Loss Drugs Sales Forecast by Type (2023-2028) & (K Tablets)

Table 85. Global Weight Loss Drugs Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Weight Loss Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Weight Loss Drugs Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Weight Loss Drugs Sales Forecast by Application (2023-2028) & (K Tablets)

Table 89. Global Weight Loss Drugs Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Weight Loss Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Weight Loss Drugs Revenue Market Share Forecast by Application (2023-2028)

Table 92. Roche Basic Information, Weight Loss Drugs Manufacturing Base, Sales Area and Its Competitors

Table 93. Roche Weight Loss Drugs Product Offered

Table 94. Roche Weight Loss Drugs Sales (K Tablets), Revenue ($ Million), Price (USD/Tablet) and Gross Margin (2020-2022)

Table 95. Roche Main Business

Table 96. Roche Latest Developments

Table 97. GSK group Basic Information, Weight Loss Drugs Manufacturing Base, Sales Area and Its Competitors

Table 98. GSK group Weight Loss Drugs Product Offered

Table 99. GSK group Weight Loss Drugs Sales (K Tablets), Revenue ($ Million), Price (USD/Tablet) and Gross Margin (2020-2022)

Table 100. GSK group Main Business

Table 101. GSK group Latest Developments

Table 102. Teva Basic Information, Weight Loss Drugs Manufacturing Base, Sales Area and Its Competitors

Table 103. Teva Weight Loss Drugs Product Offered

Table 104. Teva Weight Loss Drugs Sales (K Tablets), Revenue ($ Million), Price (USD/Tablet) and Gross Margin (2020-2022)

Table 105. Teva Main Business

Table 106. Teva Latest Developments

Table 107. Sandoz(Novartis) Basic Information, Weight Loss Drugs Manufacturing Base, Sales Area and Its Competitors

Table 108. Sandoz(Novartis) Weight Loss Drugs Product Offered

Table 109. Sandoz(Novartis) Weight Loss Drugs Sales (K Tablets), Revenue ($ Million), Price (USD/Tablet) and Gross Margin (2020-2022)

Table 110. Sandoz(Novartis) Main Business

Table 111. Sandoz(Novartis) Latest Developments

Table 112. STADA-VN J.V.Co., Ltd Basic Information, Weight Loss Drugs Manufacturing Base, Sales Area and Its Competitors

Table 113. STADA-VN J.V.Co., Ltd Weight Loss Drugs Product Offered

Table 114. STADA-VN J.V.Co., Ltd Weight Loss Drugs Sales (K Tablets), Revenue ($ Million), Price (USD/Tablet) and Gross Margin (2020-2022)

Table 115. STADA-VN J.V.Co., Ltd Main Business

Table 116. STADA-VN J.V.Co., Ltd Latest Developments

Table 117. Hexal AG Basic Information, Weight Loss Drugs Manufacturing Base, Sales Area and Its Competitors

Table 118. Hexal AG Weight Loss Drugs Product Offered

Table 119. Hexal AG Weight Loss Drugs Sales (K Tablets), Revenue ($ Million), Price (USD/Tablet) and Gross Margin (2020-2022)

Table 120. Hexal AG Main Business

Table 121. Hexal AG Latest Developments

Table 122. National Company For Pharmaceutical Industry Basic Information, Weight Loss Drugs Manufacturing Base, Sales Area and Its Competitors

Table 123. National Company For Pharmaceutical Industry Weight Loss Drugs Product Offered

Table 124. National Company For Pharmaceutical Industry Weight Loss Drugs Sales (K Tablets), Revenue ($ Million), Price (USD/Tablet) and Gross Margin (2020-2022)

Table 125. National Company For Pharmaceutical Industry Main Business

Table 126. National Company For Pharmaceutical Industry Latest Developments

Table 127. Lunan Pharmaceutical Group Corporation Basic Information, Weight Loss Drugs Manufacturing Base, Sales Area and Its Competitors

Table 128. Lunan Pharmaceutical Group Corporation Weight Loss Drugs Product Offered

Table 129. Lunan Pharmaceutical Group Corporation Weight Loss Drugs Sales (K Tablets), Revenue ($ Million), Price (USD/Tablet) and Gross Margin (2020-2022)

Table 130. Lunan Pharmaceutical Group Corporation Main Business

Table 131. Lunan Pharmaceutical Group Corporation Latest Developments

Table 132. Zein Pharmaceutical Basic Information, Weight Loss Drugs Manufacturing Base, Sales Area and Its Competitors

Table 133. Zein Pharmaceutical Weight Loss Drugs Product Offered

Table 134. Zein Pharmaceutical Weight Loss Drugs Sales (K Tablets), Revenue ($ Million), Price (USD/Tablet) and Gross Margin (2020-2022)

Table 135. Zein Pharmaceutical Main Business

Table 136. Zein Pharmaceutical Latest Developments

Table 137. Hisun Basic Information, Weight Loss Drugs Manufacturing Base, Sales Area and Its Competitors

Table 138. Hisun Weight Loss Drugs Product Offered

Table 139. Hisun Weight Loss Drugs Sales (K Tablets), Revenue ($ Million), Price (USD/Tablet) and Gross Margin (2020-2022)

Table 140. Hisun Main Business

Table 141. Hisun Latest Developments

Table 142. Taj Pharmaceuticals Ltd Basic Information, Weight Loss Drugs Manufacturing Base, Sales Area and Its Competitors

Table 143. Taj Pharmaceuticals Ltd Weight Loss Drugs Product Offered

Table 144. Taj Pharmaceuticals Ltd Weight Loss Drugs Sales (K Tablets), Revenue ($ Million), Price (USD/Tablet) and Gross Margin (2020-2022)

Table 145. Taj Pharmaceuticals Ltd Main Business

Table 146. Taj Pharmaceuticals Ltd Latest Developments

Table 147. Kabir Life Sciences & Research Basic Information, Weight Loss Drugs Manufacturing Base, Sales Area and Its Competitors

Table 148. Kabir Life Sciences & Research Weight Loss Drugs Product Offered

Table 149. Kabir Life Sciences & Research Weight Loss Drugs Sales (K Tablets), Revenue ($ Million), Price (USD/Tablet) and Gross Margin (2020-2022)

Table 150. Kabir Life Sciences & Research Main Business

Table 151. Kabir Life Sciences & Research Latest Developments

Table 152. Dm Pharma Basic Information, Weight Loss Drugs Manufacturing Base, Sales Area and Its Competitors

Table 153. Dm Pharma Weight Loss Drugs Product Offered

Table 154. Dm Pharma Weight Loss Drugs Sales (K Tablets), Revenue ($ Million), Price (USD/Tablet) and Gross Margin (2020-2022)

Table 155. Dm Pharma Main Business

Table 156. Dm Pharma Latest Developments

Table 157. China Zhongshan Pharm Basic Information, Weight Loss Drugs Manufacturing Base, Sales Area and Its Competitors

Table 158. China Zhongshan Pharm Weight Loss Drugs Product Offered

Table 159. China Zhongshan Pharm Weight Loss Drugs Sales (K Tablets), Revenue ($ Million), Price (USD/Tablet) and Gross Margin (2020-2022)

Table 160. China Zhongshan Pharm Main Business

Table 161. China Zhongshan Pharm Latest Developments

List of Figures

Figure 1. Picture of Weight Loss Drugs

Figure 2. Weight Loss Drugs Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Weight Loss Drugs Sales Growth Rate 2017-2028 (K Tablets)

Figure 7. Global Weight Loss Drugs Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Weight Loss Drugs Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Liauid Weight Loss Drugs

Figure 10. Product Picture of Tablets Weight Loss Drugs

Figure 11. Global Weight Loss Drugs Sales Market Share by Type in 2021

Figure 12. Global Weight Loss Drugs Revenue Market Share by Type (2017-2022)

Figure 13. Weight Loss Drugs Consumed in Weight-reducing Aid

Figure 14. Global Weight Loss Drugs Market: Weight-reducing Aid (2017-2022) & (K Tablets)

Figure 15. Weight Loss Drugs Consumed in Other

Figure 16. Global Weight Loss Drugs Market: Other (2017-2022) & (K Tablets)

Figure 17. Global Weight Loss Drugs Sales Market Share by Application (2017-2022)

Figure 18. Global Weight Loss Drugs Revenue Market Share by Application in 2021

Figure 19. Weight Loss Drugs Revenue Market by Company in 2021 ($ Million)

Figure 20. Global Weight Loss Drugs Revenue Market Share by Company in 2021

Figure 21. Global Weight Loss Drugs Sales Market Share by Geographic Region (2017-2022)

Figure 22. Global Weight Loss Drugs Revenue Market Share by Geographic Region in 2021

Figure 23. Global Weight Loss Drugs Sales Market Share by Region (2017-2022)

Figure 24. Global Weight Loss Drugs Revenue Market Share by Country/Region in 2021

Figure 25. Americas Weight Loss Drugs Sales 2017-2022 (K Tablets)

Figure 26. Americas Weight Loss Drugs Revenue 2017-2022 ($ Millions)

Figure 27. APAC Weight Loss Drugs Sales 2017-2022 (K Tablets)

Figure 28. APAC Weight Loss Drugs Revenue 2017-2022 ($ Millions)

Figure 29. Europe Weight Loss Drugs Sales 2017-2022 (K Tablets)

Figure 30. Europe Weight Loss Drugs Revenue 2017-2022 ($ Millions)

Figure 31. Middle East & Africa Weight Loss Drugs Sales 2017-2022 (K Tablets)

Figure 32. Middle East & Africa Weight Loss Drugs Revenue 2017-2022 ($ Millions)

Figure 33. Americas Weight Loss Drugs Sales Market Share by Country in 2021

Figure 34. Americas Weight Loss Drugs Revenue Market Share by Country in 2021

Figure 35. United States Weight Loss Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 36. Canada Weight Loss Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 37. Mexico Weight Loss Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 38. Brazil Weight Loss Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 39. APAC Weight Loss Drugs Sales Market Share by Region in 2021

Figure 40. APAC Weight Loss Drugs Revenue Market Share by Regions in 2021

Figure 41. China Weight Loss Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 42. Japan Weight Loss Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 43. South Korea Weight Loss Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 44. Southeast Asia Weight Loss Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 45. India Weight Loss Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 46. Australia Weight Loss Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 47. Europe Weight Loss Drugs Sales Market Share by Country in 2021

Figure 48. Europe Weight Loss Drugs Revenue Market Share by Country in 2021

Figure 49. Germany Weight Loss Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 50. France Weight Loss Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 51. UK Weight Loss Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 52. Italy Weight Loss Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 53. Russia Weight Loss Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 54. Middle East & Africa Weight Loss Drugs Sales Market Share by Country in 2021

Figure 55. Middle East & Africa Weight Loss Drugs Revenue Market Share by Country in 2021

Figure 56. Egypt Weight Loss Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 57. South Africa Weight Loss Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 58. Israel Weight Loss Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 59. Turkey Weight Loss Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 60. GCC Country Weight Loss Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 61. Manufacturing Cost Structure Analysis of Weight Loss Drugs in 2021

Figure 62. Manufacturing Process Analysis of Weight Loss Drugs

Figure 63. Industry Chain Structure of Weight Loss Drugs

Figure 64. Channels of Distribution

Figure 65. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390